LHC Group Announces Third Quarter 2018 Financial Results

Affirms Guidance and Expectations for 12% to 15% Adjusted Earnings Accretion from Almost Family Acquisition in 2018

LAFAYETTE, La., Oct. 31, 2018 (GLOBE NEWSWIRE) -- LHC Group, Inc. (NASDAQ: LHCG) announced its financial results for the three and nine months ended September 30, 2018.

Financial Results for the Third Quarter of 2018

  • Net service revenue increased 88.0% to $507.0 million compared with $269.7 million in the third quarter of 2017. Net service revenue prior to implicit price concession increased 88.4% to $514.1 million compared with $272.9 million in the third quarter of 2017.
  • Net income attributable to LHC Group’s common stockholders was $21.2 million, a 94.7% increase from $10.9 million in the third quarter of 2017. Net income attributable to LHC Group’s common stockholders per diluted share was $0.68, an increase of 11.5% from $0.61 in the third quarter of 2017, on a 72.6% increase in weighted average diluted shares outstanding as well as the effect of costs and expenses described within the adjusted results below.
  • Adjusted net income attributable to LHC Group’s common stockholders was $29.5 million, up 156% from $11.5 million in the third quarter of 2017.  Adjusted net income attributable to LHC Group’s common stockholders per diluted share was $0.95, a 48.4% increase from $0.64 in the third quarter of 2017. (1)
  • Adjusted results for the third quarter of 2018 exclude transaction and other transition related costs, expenses related to certain closures and relocations and the excess tax benefit due to the exercise of stock options related to the Almost Family acquisition in the aggregate amount of $8.3 million after tax, or $0.27 per diluted share.
  • The Company’s Healthcare Innovations segment recorded $3.7 million in revenue related to the Medicare Shared Savings Program for the plan year ended December 31, 2017, in which the Company participates through multiple Accountable Care Organizations (ACO’s). This represents an increase of $1.2 million over the $2.5 million in revenue that was recorded in 2017 for the plan year ended December 31, 2016.

(1) See “Reconciliation of Non-GAAP Measures – Adjusted net income attributable to LHC Group” to GAAP results on page 11.

Operational and Strategic Highlights

  • LHC Group quality and patient satisfaction results continue to exceed the national average with 98% of its same store locations having CMS Quality Star ratings of four stars or greater.
  • Total growth in home health admissions was 94.1%; organic growth was 9.7%.
  • Total growth in home health revenue was 83.4%; organic growth was 9.3%.
  • Total growth in hospice admissions was 32.5%; organic growth was 5.1%.
  • Our number of ACO’s under Company management for the year ended December 31, 2018 increased to 30 ACO’s covering 460,000 Medicare lives from 16 in 2017 which covered 140,000 Medicare lives.

Commenting on the results, Keith G. Myers, LHC Group’s Chairman and Chief Executive Officer, said, “LHC Group’s strong performance continues to resonate across the industry with growing recognition by hospitals, payors and other stakeholders of the crucial role we play in the homes and communities of the patients and families we are privileged to serve. The organic growth we have generated to date in 2018 demonstrates the fruits of our commitment to quality, efficiency, and clinical outcomes across a national in-home healthcare platform. We have extended this same commitment to pursuing new growth opportunities as well, with the completion of the $800 million acquisition of Almost Family, five new joint ventures, and other select acquisitions in 2018. With such a strong foundation of diversified growth, we expect continued disciplined deployment of capital to accelerate our earnings growth for years to come.

“LHC Group is uniquely positioned to thrive in both the industry’s present environment and in the future as we shift to value-based reimbursement. Our unique positioning is enhanced by a growing number of hospitals and health systems that recognize the inherent value of our business model and our ability to create high-performing post-acute networks for them. The experience we have gained through the ownership of one of the nation’s largest Accountable Care Organization management companies is also a considerable and virtually unmatched asset that increases our appeal to payors, hospitals and other risk-bearing entities.”

Fiscal Year 2018 Guidance
The Company re-affirmed its guidance for fiscal year 2018 issued on May 2, 2018. Net service revenue is expected to be in a range of $1.81 billion to $1.86 billion, and adjusted earnings per diluted share is expected to be in a range of $3.45 to $3.55. The guidance assumes the following:

  • The Company expects to achieve a total of $25 million in pre-tax synergies in connection with the Almost Family transaction, with $8 million to $12 million realized in 2018 (of which approximately $6.6 million has been realized through the third quarter of 2018); 
  • An estimated effective tax rate of 28% to 29%, which reflects the positive impact from passage of the Tax Cuts and Jobs Act of 2017; and
  • Weighted average diluted shares of approximately 28.0 million for the full year of 2018.

The Company’s guidance ranges do not take into account the impact of future reimbursement changes, if any, future acquisitions, if made, de novo locations, if opened, location closures, if any, or future legal expenses, if necessary. The adjusted earnings guidance for 2018 is presented on a non-GAAP basis, as it does not include the impact of transaction related costs, integration related expenses or other expenses related to the acquisition of Almost Family or other acquisitions. Given the difficulty in predicting the future amount and timing of these expenses, the Company cannot reasonably provide a full reconciliation of its fiscal year 2018 adjusted earnings per share guidance to GAAP earnings per share.

Commenting on the 2018 outlook, Joshua L. Proffitt, LHC Group’s Chief Financial Officer, added, “We are experiencing an unprecedented year of growth. Our industry leading quality scores combined with our disciplined go-to-market strategies are generating strong same-store admissions growth, and our inorganic growth will continue to be fueled by the benefits from the Almost Family acquisition, contributions from other acquisitions completed in 2018 as well as those currently under consideration in a very robust pipeline. The combination of these different growth levers and the success to date in integrating the Almost Family operations give us the confidence that we will achieve the 12% to 15% adjusted earnings accretion from the Almost Family acquisition in 2018 and continue to experience accelerated revenue and earnings growth well into the future.” 

Conference Call
LHC Group will host a conference call on Thursday, November 1, 2018, at 11:00 a.m. Eastern time to discuss its third quarter 2018 results. The toll-free number to call for this interactive teleconference is (866) 393‑1608 (international callers: (973) 890-8327). A telephonic replay of the conference call will be available through midnight on November 8, 2018, by dialing (855) 859‑2056 (international callers: (404) 537-3406) and entering confirmation number 5649718.

A live broadcast of LHC Group’s conference call will be available on the Investor Relations section of the Company’s website, www.LHCgroup.com. A one-year online replay will be available approximately an hour following the conclusion of the live broadcast.

About LHC Group, Inc.
LHC Group, Inc. is a national provider of in-home healthcare services and innovations, providing quality, value-based healthcare to patients primarily within the comfort and privacy of their home or place of residence. LHC Group’s services cover a wide range of healthcare needs for patients and families dealing with illness, injury, or chronic conditions. The company’s 32,000 employees deliver home health, hospice, home and community based services, and facility-based care from more than 780 locations in communities in 36 states. Through its healthcare innovations business, LHC Group drives increased utilization of home healthcare and enhances patient and caregiver engagement. LHC Group is the preferred in-home healthcare partner for 330 leading hospitals around the country.

Forward-looking Statements
This press release contains “forward-looking statements” (as defined in the Securities Litigation Reform Act of 1995) regarding, among other things, future events or the future financial performance of the Company, or anticipated benefits of the transaction. Words such as “anticipate,” “expect,” “project,” “intend,” “believe,” “will,” “estimates,” “may,” “could,” “should” and words and terms of similar substance used in connection with any discussion of future plans, actions or events identify forward-looking statements. Forward-looking statements contained in this press release include, but are not limited to: our 2018 revenue and earnings guidance, statements about the benefits of the acquisition, including anticipated earnings accretion, synergies and cost savings and the timing thereof; the Company’s plans, objectives, expectations, projections and intentions; and other statements relating to the transaction that are not historical facts. Forward-looking statements are based on information currently available to the Company and involve estimates, expectations and projections. Investors are cautioned that all such forward-looking statements are subject to risks and uncertainties, and important factors could cause actual events or results to differ materially from those indicated by such forward-looking statements. With respect to the acquisition, these risks, uncertainties and factors include, but are not limited to: the risk that the businesses will not be integrated successfully; the risk that the cost savings, synergies and growth from the transaction may not be fully realized or may take longer to realize than expected; the diversion of management time on integration-related issues; and the risk that costs associated with the integration of the businesses are higher than anticipated. With respect to the Company’s  businesses, these risks, uncertainties and factors include, but are not limited to: changes in, or failure to comply with, existing government regulations that impact the Company’s businesses; legislative proposals for healthcare reform; the impact of changes in future interpretations of fraud, anti-kickback, or other laws; changes in Medicare and Medicaid reimbursement levels; changes in laws and regulations with respect to Accountable Care Organizations; changes in the marketplace and regulatory environment for Health Risk Assessments; decrease in demand for the Company’s services; the potential impact of the transaction on relationships with customers, joint venture and other partners, competitors, management and other employees, including the loss of significant contracts or reduction in revenues associated with major payor sources; ability of customers to pay for services; risks related to any current or future litigation proceedings; potential audits and investigations by government and regulatory agencies, including the impact of any negative publicity or litigation; the ability to attract new customers and retain existing customers in the manner anticipated; the ability to hire and retain key personnel; increased competition from other entities offering similar services as offered by the  Company; reliance on and integration of information technology systems; ability to protect intellectual property rights; impact of security breaches, cyber-attacks or fraudulent activity on the Company’s reputation; the risks associated with assumptions the parties make in connection with the parties’ critical accounting estimates and legal proceedings; the risks associated with the Company’s expansion strategy, the successful integration of recent acquisitions, and if necessary, the ability to relocate or restructure current facilities; and the potential impact of an economic downturn or effects of tax assessments or tax positions taken, risks related to goodwill and other intangible asset impairment, tax adjustments, anticipated tax rates, benefit or retirement plan costs, or other regulatory compliance costs.

Many of these risks, uncertainties and assumptions are beyond the Company’s ability to control or predict. Because of these risks, uncertainties and assumptions, you should not place undue reliance on these forward-looking statements. Furthermore, forward-looking statements speak only as of the information currently available to the Company on the date they are made, and the Company does not undertake any obligation to update publicly or revise any forward-looking statements to reflect events or circumstances that may arise after the date of this press release. The Company does not give any assurance (1) that the Company will achieve its guidance or expectations, or (2) concerning any result or the timing thereof. All subsequent written and oral forward-looking statements concerning the transaction or other matters and attributable to the Company or any person acting on their behalf are expressly qualified in their entirety by the cautionary statements above.


LHC GROUP, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS
(Amounts in thousands, except share data)

  September 30,   December 31,
 2018 2017
  (Unaudited)    
ASSETS      
Current assets:      
Cash $ 56,973     $ 2,849  
Receivables:      
Patient accounts receivable 258,254     161,898  
Other receivables 9,929     3,163  
Amounts due from governmental entities 830     830  
Total receivables 269,013     165,891  
Prepaid income taxes     7,006  
Prepaid expenses 23,058     13,042  
Other current assets 18,139     12,177  
Total current assets 367,183     200,965  
Property, building and equipment, net of accumulated depreciation of $52,804 and $43,565, respectively 66,315     46,453  
Goodwill 1,152,232     392,601  
Intangible assets, net of accumulated amortization of $14,789 and $13,041, respectively 301,411     134,610  
Assets held for sale 2,850      
Other assets 20,773     19,073  
Total assets $ 1,910,764     $ 793,702  
LIABILITIES AND STOCKHOLDERS’ EQUITY      
Current liabilities:      
Accounts payable and other accrued liabilities $ 63,741     $ 39,750  
Salaries, wages, and benefits payable 113,430     44,747  
Self-insurance reserve 33,456     12,450  
Income tax payable 877        
Current portion of long-term debt 12,552     286  
Amounts due to governmental entities 4,508     5,019  
Total current liabilities 228,564     102,252  
Deferred income taxes 25,184     27,466  
Income taxes payable 2,596      
Revolving credit facility 242,000     144,000  
Long term notes payable 989      
Total liabilities 499,333     273,718  
Noncontrolling interest — redeemable 14,737     13,393  
Stockholders’ equity:      
LHC Group, Inc. stockholders’ equity:      
Preferred stock – $0.01 par value; 5,000,000 shares authorized; none issued or outstanding      
Common stock — $0.01 par value; 60,000,000 and 40,000,000 shares authorized in 2018 and 2017, respectively; 35,632,076 and 22,640,046 shares issued in 2018 and 2017, respectively 356     226  
Treasury stock —  4,958,423 and 4,890,504 shares at cost, respectively (48,968 )   (42,249 )
Additional paid-in capital 935,158     126,490  
Retained earnings 407,423     364,401  
Total LHC Group, Inc. stockholders’ equity 1,293,969     448,868  
Noncontrolling interest — non-redeemable 102,725     57,723  
Total equity 1,396,694     506,591  
Total liabilities and equity $ 1,910,764     $ 793,702  
 


LHC GROUP, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF INCOME
(Amounts in thousands, except share and per share data)
(Unaudited)

  Three Months Ended
 September 30,
  Nine Months Ended
September 30,
  2018   2017   2018(1)   2017
Net service revenue $ 507,043     $ 269,678     $ 1,300,121     $ 771,462  
Cost of service revenue 322,196     172,856     831,818     488,384  
Gross margin 184,847     96,822     468,303     283,078  
General and administrative expenses 149,917     75,492     391,940     221,054  
Operating income 34,930     21,330     76,363     62,024  
Interest expense (3,264 )   (995 )   (7,916 )   (2,615 )
Income before income taxes and noncontrolling interest 31,666     20,335     68,447     59,409  
Income tax expense 6,685     7,445     14,832     20,410  
Net income 24,981     12,890     53,615     38,999  
Less net income attributable to noncontrolling interests 3,751     1,984     10,593     7,321  
Net income attributable to LHC Group, Inc.’s common stockholders $ 21,230     $ 10,906     $ 43,022     $ 31,678  
Earnings per share attributable to LHC Group, Inc.'s common stockholders:              
Basic $ 0.69     $ 0.61     $ 1.63     $ 1.79  
Diluted $ 0.68     $ 0.61     $ 1.61     $ 1.77  
Weighted average shares outstanding:              
Basic 30,750,227     17,740,818     26,393,337     17,704,561  
Diluted 31,083,815     18,010,522     26,640,774     17,931,700  

(1) Certain acquired employee salaries that were previously classified in costs of service revenue for the second quarter of 2018 were reclassified into general and administrative expenses for the three and nine months ended September 30, 2018 to align with the Company’s historical presentation of such job functions as employee roles were clarified during the payroll integration process. 


LHC GROUP, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(Amounts in thousands)
(Unaudited)

  Nine Months Ended
September 30,
  2018   2017
Operating activities:      
Net income $ 53,615     $ 38,999  
Adjustments to reconcile net income to net cash provided by operating activities:      
Depreciation and amortization expense 11,986     9,680  
Stock-based compensation expense 7,336     4,522  
Deferred income taxes 2,915     6,245  
(Loss) gain on disposal of assets 4     (23 )
Impairment of intangibles and other 1,123     81  
Changes in operating assets and liabilities, net of acquisitions:      
Receivables (5,693 )   (11,331 )
Prepaid expenses and other assets (7,489 )   (3,859 )
Prepaid income taxes 9,710     (4,879 )
Accounts payable and accrued expenses 13,862     26,038  
Income taxes payable (313 )   (3,499 )
Net amounts due to/from governmental entities (722 )   (279 )
Net cash provided by operating activities 86,334     61,695  
Investing activities:      
Purchases of property, building and equipment (18,889 )   (7,944 )
Cash acquired from business combination, net of cash paid 9,070     (61,247 )
Net cash used in investing activities (9,819 )   (69,191 )
Financing activities:      
Proceeds from line of credit 292,084     63,000  
Payments on line of credit (300,884 )   (31,000 )
Proceeds from employee stock purchase plan 1,015     776  
Payments on debt (196 )   (192 )
Payments on deferred financing fees (1,881 )    
Noncontrolling interest distributions (8,720 )   (8,406 )
Withholding taxes paid on stock-based compensation (6,719 )   (3,091 )
Purchase of additional controlling interest (412 )   (184 )
Sale of noncontrolling interest 3,322     251  
Net cash (used in) provided by financing activities (22,391 )   21,154  
Change in cash 54,124     13,658  
Cash at beginning of period 2,849     3,264  
Cash at end of period $ 56,973     $ 16,922  
Supplemental disclosures of cash flow information:      
Interest paid $ 6,127     $ 2,694  
Income taxes paid $ 2,929     $ 22,376  



LHC GROUP, INC. AND SUBSIDIARIES
SEGMENT INFORMATION
(Amounts in thousands)
(Unaudited)

  Three Months Ended September 30, 2018
  Home health
services
  Hospice
services
  Home and
community-
based
services
  Facility-
based
services
  HCI   Total
Net service revenue $ 360,000     $ 52,962     $   52,773     $ 27,891     $ 13,417     $ 507,043  
Cost of service revenue 222,765     34,540       39,860     20,146     4,885     322,196  
General and administrative expenses 105,457     14,685       12,922     9,823     7,030     149,917  
Operating income (loss) 31,778     3,737       (9 )   (2,078 )   1,502     34,930  
Interest expense (2,284 )   (491 )     (163 )   (163 )   (163 )   (3,264 )
Income (loss) before income taxes and noncontrolling interest 29,494     3,246       (172 )   (2,241 )   1,339     31,666  
Income tax expense (benefit) 6,209     774       (74 )   (541   317     6,685  
Net income (loss) 23,285     2,472       (98 )   (1,700 )   1,022     24,981  
Less net income (loss) attributable to noncontrolling interests 3,425     386       (87 )   27         3,751  
Net income (loss) attributable to LHC Group, Inc.’s common stockholders $ 19,860     $ 2,086     $ (11 )   $ (1,727 )   $ 1,022     $ 21,230  
Total assets $ 1,316,792     $ 203,921     $ 246,963     $ 61,089     $ 81,999     $ 1,910,764  


  Three Months Ended September 30, 2017
  Home health
services
  Hospice
services
  Home and
community-
based
services
  Facility-
based
services
  HCI   Total
Net service revenue $ 196,317     $ 41,057     $   12,116     $ 20,188     $     $ 269,678  
Cost of service revenue 123,204     27,441       8,971     13,240         172,856  
General and administrative expenses 56,000     11,276       2,387     5,829         75,492  
Operating income 17,113     2,340       758     1,119         21,330  
Interest expense (746 )   (149 )     (50 )   (50 )       (995 )
Income before income taxes and noncontrolling interest 16,367     2,191       708     1,069         20,335  
Income tax expense 5,703     931       338     473         7,445  
Net income 10,664     1,260       370     596         12,890  
Less net income (loss) attributable to noncontrolling interests 1,759     273       (21 )   (27       1,984  
Net income attributable to LHC Group, Inc.’s common stockholders $ 8,905     $ 987     $ 391     $ 623     $     $ 10,906  
Total assets $ 515,562     $ 156,296     $ 44,621     $ 48,574     $     $ 765,053  



LHC GROUP, INC. AND SUBSIDIARIES
SEGMENT INFORMATION (Continued)
(Amounts in thousands)
(Unaudited)

  Nine Months Ended
 September 30, 2018
  Home
health
services
  Hospice
services
  Home and
community-
based
services
  Facility-
based
services
  HCI   Total
Net service revenue $ 924,463     $ 146,142     $ 119,617     $ 86,345     $ 23,554     $ 1,300,121  
Cost of service revenue 576,416     95,557       90,331     59,102     10,412     831,818  
General and administrative expenses 277,711     43,090       28,664     30,058     12,417     391,940  
Operating income 70,336     7,495       622     (2,815 )   725     76,363  
Interest expense (5,627 )   (1,181 )     (393 )   (395 )   (320 )   (7,916 )
Income (loss) before income taxes and noncontrolling interest 64,709     6,314       229     (3,210 )   405     68,447  
Income tax expense (benefit) 14,022     1,368       50     (695   87     14,832  
Net income (loss) 50,687     4,946       179     (2,515 )   318     53,615  
Less net income (loss) attributable to noncontrolling interests   9,472       1,215         (157 )      129       (66 )     10,593  
Net income (loss) attributable to LHC Group, Inc.’s common stockholders $ 41,215     $ 3,731     $ 336     $ (2,644 )   $ 384     $ 43,022  


  Nine Months Ended
 September 30, 2017
  Home
health
services
  Hospice
services
  Home and
community-
based
services
  Facility-
based
services
  HCI   Total
Net service revenue $ 569,384     $ 114,856     $   33,403     $ 53,819     $     $ 771,462  
Cost of service revenue 352,896     75,187       24,905     35,396         488,384  
General and administrative expenses 165,192     32,425       6,957     16,480         221,054  
Operating income 51,296     7,244       1,541     1,943         62,024  
Interest expense (1,961 )   (393 )     (130 )   (131 )       (2,615 )
Income before income taxes and noncontrolling interest 49,335     6,851       1,411     1,812         59,409  
Income tax expense 16,712     2,439       602     657         20,410  
Net income 32,623     4,412       809     1,155         38,999  
Less net income (loss) attributable to noncontrolling interests   6,053       1,038       (7 )     237             7,321  
Net income attributable to LHC Group, Inc.’s common stockholders $ 26,570     $ 3,374     $ 816     $ 918     $     $ 31,678  



LHC GROUP, INC. AND SUBSIDIARIES
SELECT CONSOLIDATED KEY STATISTICAL AND FINANCIAL DATA
(Unaudited)

  Three Months Ended
September 30,
  Nine Months Ended
September 30,
  2018   2017
  2018   2017
         
Key Data:
 
       
Home-Health Services:        
Locations   565       320       565       320  
Acquired   2       8       256       40  
De novo                      
Divested/Consolidated   (5 )     (2 )     (10 )     (5 )
Total new admissions   92,643       47,727       239,671       142,448  
Medicare new admissions   57,118       29,848       149,158       89,432  
Average daily census   75,479       43,239       76,080       42,677  
Average Medicare daily census   49,948       29,511       50,768       29,374  
Medicare completed and billed episodes   90,536       54,003       241,226       158,762  
Average Medicare case mix for completed
  and billed Medicare episodes
  1.10       1.10       1.10       1.09  
Average reimbursement per completed
  and billed Medicare episodes
$ 2,968     $ 2,797     $ 2,929     $ 2,765  
Total visits   2,471,979       1,429,024       6,472,307       4,208,020  
Total Medicare visits   1,662,610       981,756       4,375,408       2,912,092  
Average visits per completed
  and billed Medicare episodes
  18.4       18.3       18.1       18.3  
Organic growth:(1)        
Net revenue   9.3 %     10.3 %     9.1 %     10.3 %
Net Medicare revenue   4.6 %     4.9 %     4.8 %     5.6 %
Total new admissions   9.7 %     6.2 %     7.9 %     9.7 %
Medicare new admissions   4.6 %     1.7 %     4.9 %     5.5 %
Average daily census   2.9 %     3.7 %     2.8 %     4.0 %
Average Medicare daily census   -0.9 %     -1.2 %     -0.9 %     -0.7 %
Medicare completed and billed episodes   0.7 %     2.0 %     1.0 %     1.2 %
         
Home and Community-Based Services:        
Locations   80       12       80       12  
Acquired         1       64       1  
De novo               4        
Divested/Consolidated                      
Average daily census   14,455       1,933       14,511       1,785  
Billable hours   2,284,980       421,629       4,991,594       1,174,409  
Revenue per billable hour $ 23.41     $ 28.81     $ 24.35     $ 28.79  
         
Hospice-Based Services:        
Locations   104       92       104       92  
Acquired   1       6       16       27  
De novo                      
Divested/Consolidated   (3 )     (1 )     (3 )     (1 )
Admissions   4,557       3,438       13,139       9,714  
Average daily census   3,804       3,109       3,540       2,987  
Patient days   346,153       286,002       962,839       815,361  
Average revenue per patient day $ 155     $ 144     $ 154     $ 143  
         
Facility-Based Services:        
Long-term Acute Care        
Locations   12       15       12       15  
Acquired         6             6  
Divested/Consolidated               (2 )      
Patient days   21,617       14,642       62,654       41,449  
Average revenue per patient day $ 1,183     $ 1,248     $ 1,300     $ 1,143  
Occupancy rate   76.6 %     68.3 %     74.3 %     74.8 %

 (1) Organic growth is calculated as the sum of same store plus de novo for the period divided by total from the same period in the prior year.


LHC GROUP, INC. AND SUBSIDIARIES
RECONCILIATION OF REVENUE AFTER ADOPTION OF ASU 2014-09
(Amounts in thousands, Unaudited)

  Three Months Ended
September 30,

  Nine Months Ended
September 30,
  2018   2017    2018    2017
Net Service Revenue, pre-adoption $   514,118   $   272,872   $   1,319,840   $   779,700
Less: Implicit price concession (1)     7,075       3,194       19,719       8,238
Net Service Revenue, post-adoption $   507,043   $   269,678   $   1,300,121   $   771,462
                       

RECONCILIATION OF ADJUSTED NET INCOME ATTRIBUTABLE TO LHC GROUP, INC.
(Amounts in thousands, Unaudited)

  Three Months Ended
September 30,

  Nine Months Ended
September 30,
  2018   2017   2018   2017
Net income attributable to LHC Group, Inc.’s common stockholders $ 21,230   $ 10,906   $ 43,022   $ 31,678
Add (net of tax):        
AFAM and other acquisition expenses (2)   7,118         19,289    
Closures/relocations (3)   2,335     129     4,799     129
Excess tax benefit (4)   (1,200 )       (1,200 )  
Income tax effect of adjustments to income (5)           689    
CHRISTUS Health JV costs       483         483
Adjusted net income attributable to
  LHC Group, Inc.’s common stockholders
$ 29,483   $ 11,518   $ 66,599   $ 32,290
                       

RECONCILIATION OF ADJUSTED NET INCOME
ATTRIBUTABLE TO LHC GROUP, INC. PER DILUTED SHARE
 (Unaudited)

  Three Months Ended
September 30,

  Nine Months Ended
September 30,
  2018   2017
  2018   2017
Net income attributable to LHC Group, Inc.’s common stockholders $ 0.68   $ 0.61   $ 1.61   $ 1.77
Add (net of tax):            
AFAM and other acquisition expenses (2)   0.23         0.72  
Closures/relocations (3)   0.08     0.01     0.18     0.01
Excess tax benefit (4)   (0.04 )       (0.05 )  
Income tax effect of adjustments to income (5)           0.03    
CHRISTUS Health JV costs       0.02         0.02
Adjusted net income attributable to
    LHC Group, Inc.’s common stockholders
$ 0.95   $ 0.64   $ 2.49   $ 1.80

(1) All amounts previously classified as provision for bad debts are now classified as implicit price concessions in determining the transaction price of the Company's net service revenue.
(2) Transition and integration costs associated with the acquisition of Almost Family ($9.9 million pre-tax in the three months ended September 30, 2018 and $27.1 million in the nine months ended September 30, 2018).
(3) Expenses associated with the closure or consolidation of two home health agencies, three hospice agencies and two hospice inpatient units along with costs associated with the relocation of two long-term acute care hospitals. ($3.3 million pre-tax in the three months ended September 30, 2018 and $6.8 million in the nine months ended September 30, 2018)
(4) Tax benefit due to the exercise of stock options related to the Almost Family acquisition.
(5) The year-to-date effective tax rate was 25.6% as excess tax benefits exceeded the impact of certain deal and transaction costs that are not deductible related to the acquisitions. We continue to anticipate a normalized effective tax rate of 28% to 29% and have used that tax rate in the presentation of adjusted net income attributable to LHC Group and adjusted net income attributable to LHC Group per diluted share.

We have included certain financial measures in this press release, including adjusted net income attributable to LHC Group and adjusted net income attributable to LHC Group per diluted share, which are “non-GAAP financial measures” as defined under the rules and regulations promulgated by the SEC. We define adjusted net income attributable to LHC Group as net income attributable to LHC Group adjusted for the AFAM acquisition and other closure costs. We define adjusted net income attributable to LHC Group per diluted share as net income attributable to LHC Group adjusted for the AFAM acquisition and other closure costs divided by weighted average diluted shares outstanding.

Adjusted net income attributable to LHC Group and adjusted net income attributable to LHC Group per diluted share are supplemental measures of our performance and are not required by, or presented in accordance with, generally accepted accounting principles in the United States (“GAAP”). Adjusted net income attributable to LHC Group and adjusted net income attributable to LHC Group per diluted share are not measures of our financial performance under GAAP and should not be considered as alternatives to net income attributable to LHC Group, net income attributable to LHC Group per diluted share or any other performance measures derived in accordance with GAAP. Our measurements of adjusted net income attributable to LHC Group and adjusted net income attributable to LHC Group per diluted share may not be comparable to similarly titled measures of other companies. We have included information concerning adjusted net income attributable to LHC Group and adjusted net income attributable to LHC Group per diluted share in this press release because we believe that such information is used by certain investors as measures of a company’s historical performance. We believe these measures are frequently used by securities analysts, investors and other interested parties in the evaluation of issuers of equity securities, many of which present adjusted net income and adjusted net income per diluted share when reporting their results. Our presentation of adjusted net income attributable to LHC Group and adjusted net income attributable to LHC Group per diluted share should not be construed as an inference that our future results will be unaffected by unusual or nonrecurring items.

Contact:    Eric Elliott
                  Senior Vice President of Finance
                  (337) 233-1307
                  eric.elliott@lhcgroup.com

LHC Group

Source: LHC Group